Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

Togha, Mansoureh; Ahmadi Karvigh, Sanaz; Nabavi, Masoud; Beladi Moghadam, Nahid; Hossein Harirchian, Mohammad; Ali Sahraian, Mohammad; Enzevaei, Anahita; Nourian, Alireza; Ghanaati, Hossein; Firouznia, Kavous; Jannati, Ali; Shekiba, Majid

doi:10.1177/1352458510369147

Public

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

Published in Multiple Sclerosis Journal • May 20, 2010

Authors:

Mansoureh Togha

Sanaz Ahmadi Karvigh

Masoud Nabavi

Abstract

OBJECTIVES: This study was conducted to evaluate the effect of simvastatin (40 mg/day) as an adjuvant therapy to interferon beta (IFNb 1a, 30 microg once weekly) in relapsing-remitting multiple sclerosis patients, compared with placebo. METHODS: We enrolled 85 patients with relapsing-remitting multi...

Subject

Simvastatin

Medicine

Expanded Disability Status Scale

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!